he following is an excerpt from Acid Dreams author Martin A. Lee's new book  Smoke Signals: A Social History of Marijuana -- Medical, Recreational, and Scientific  (Simon and Schuster, 2012):  
Peer-reviewed scientific studies in several countries show THC and  other compounds found only in marijuana are effective not only for  cancer symptom management (pain, nausea, loss of appetite, fatigue, and  so on), but they confer a direct antitumoral effect as well.
Animal experiments conducted by Manuel Guzmán at Madrid’s Complutense  University in the late 1990s revealed that a synthetic cannabinoid  injected directly into a malignant brain tumor could eradicate it.  Reported in  Nature Medicine , this remarkable finding prompted  additional studies in Spain and elsewhere that confirmed the anticancer  properties of marijuana-derived compounds. Guzmán’s team administered  pure THC via a catheter into the tumors of nine hospitalized patients  with glioblastoma (an aggressive form of brain cancer) who had failed to  respond to standard therapies.
This was the first clinical trial  assessing the antitumoral action of cannabinoids on human beings, and  the results, published in the  British Journal of Cancer , were very promising. THC treatment was associated with significantly reduced tumor cell proliferation in all test subjects. 
Guzmán and his colleagues found that THC and its synthetic emulators  selectively killed tumor cells while leaving healthy cells unscathed.
 No  Big Pharma chemotherapy drugs could induce apoptosis (cell death) in  cancer cells without trashing the whole body. Up to 90 percent of  advanced cancer patients suffer cognitive dysfunction from “chemo  brain,” a common side effect of corporate cancer meds that  indiscriminately destroy brain matter, whereas cannabinoids are  free-radical scavengers that protect brain tissue and stimulate brain  cell growth.
There is mounting evidence that cannabinoids may “represent a new  class of anticancer drugs that retard cancer growth, inhibit  angiogenesis [the formation of new blood vessels] and the metastatic  spreading of cancer cells,” according to the scientific journal  Mini-Reviews in Medicinal Chemistry .  Studies from scientists around the world have documented the anticancer  properties of cannabinoid compounds for various malignancies, including  (but not limited to):
• Prostate cancer. Researchers at the University of Wisconsin found  that the administration of the synthetic cannabinoid WIN-55,212–2, a  CB-1and CB-2 agonist, inhibited prostate cancer cell growth and also  induced apoptosis.
•Colon cancer. British researchers demonstrated that THC triggers  cell death in tumors of the colon, the second leading cause of cancer  deaths in the United States.
• Pancreatic cancer. Spanish and French scientists determined that  cannabinoids selectively increased apoptosis in pancreatic cell lines  and reduced the growth of tumor cells in animals, while ignoring normal  cells.
• Breast cancer. Scientists at the Pacific Medical Centers in San  Francisco found that THC and other plant cannabinoids inhibited human  breast cancer cell proliferation and metastasis and shrank breast cancer  tumors. 1.3 million women worldwide are diagnosed yearly with breast  cancer and a half million succumb to the disease.
• Cervical cancer. German researchers at the University of Rostock  reported that THC and a synthetic cannabinoid suppressed the invasion of  human cervical carcinoma into surrounding tissues by stimulating the  body’s production of TIMP-1, a substance that helps healthy cells resist  cancer.
• Leukemia. Investigators at St. George’s University and  Bartholomew’s Hospital in London found that THC acts synergistically  with conventional antileukemia therapies to enhance the effectiveness of  anti-cancer agents in vitro (in a test tube or petri dish). Scientists  had previously shown that THC and cannabidiol were both potent inducers  of apoptosis in leukemic cell lines.
• Stomach cancer. According to Korean researchers at the Catholic  Uni- versity in Seoul, WIN-55,212–2, the synthetic cannabinoid, reduced  the proliferation of stomach cancer cells. 
No comments:
Post a Comment